Device / Technology News

RSS

LaVision BioTec introduce new products for their UltraMicroscope and TriM Scope microscopy products at Neuroscience 2014

LaVision BioTec, developers of advanced microscopy solutions for the life sciences, announce they will introduce new products for their UltraMicroscope and TriM Scope microscopy products at the 2014 annual meeting of the Society for Neuroscience (SfN).

13 Nov 2014

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health, today announced the introduction of ViviGen Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects.

13 Nov 2014

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes Companies of Johnson & Johnson, in collaboration with LifeNet Health®, today announced the introduction of ViviGen™ Cellular Bone Matrix, a differentiated cellular allograft for the repair or reconstruction of musculoskeletal defects.

13 Nov 2014

Scientists use Rapid Heme Panel test to identify right treatment for leukemia, other blood cancers

For patients with aggressive types of leukemia and other blood cancers, quickly identifying and starting the right treatment can make all the difference.

13 Nov 2014

Researchers develop genetic test to predict prostate cancer recurrence

Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy.

13 Nov 2014

New DNA-based test could better predict treatment outcomes for prostate cancer patients

Researchers at The Ontario Institute for Cancer Research and University Health Network, have identified a new DNA-based test that could be used to better predict how prostate cancer patients will respond to treatment and to prevent relapse.

13 Nov 2014

K2M receives FDA clearance to market CAPRI Corpectomy Cage System

K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine technologies, techniques and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market the CAPRI Corpectomy Cage System, an expandable vertebral body replacement device that provides structural stability following a corpectomy or vertebrectomy.

13 Nov 2014

BioCision announces ThawSTAR™ automated sample thawing system

BioCision, LLC, a leader in advanced products to improve biospecimen handling and standardization, today announced the availability of ThawSTAR™ automated sample thawing system, a breakthrough technology that addresses the “last mile” in the cryopreservation process. Utilizing the patent-pending STAR™ adaptive sensing technology for rapid and standardized thawing and recovery of cells and other biospecimens, ThawSTAR system tailors the thaw cycle to the specific characteristics of each frozen sample.

12 Nov 2014

New multi-specimen perfusion bioreactor for reliable tissue growth introduced by Bose

Bose Corporation has introduced the 3DCulturePro™ system, a new multi-specimen perfusion bioreactor designed for biologists, biomedical researchers and scientists who require reproducible and reliable tissue growth. The 3DCulturePro system supports cell growth and 3D tissue culture in an easy-to-use, scalable configuration.

From TA Instruments 12 Nov 2014

Encision announces launch of AEM EndoShield Burn Protection System

Encision Inc., a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it has launched its AEM EndoShield Burn Protection System ("EndoShield").

12 Nov 2014

Antibiograms could improve antibiotic effectiveness, help address problems with antibiotic resistance

Use of "antibiograms" in skilled nursing facilities could improve antibiotic effectiveness and help address problems with antibiotic resistance that are becoming a national crisis, researchers conclude in a new study.

12 Nov 2014

Enterome, AbbVie to develop novel diagnostic products, therapies for microbiome-related diseases

ENTEROME Bioscience SA, a pioneer in the development of therapeutic solutions (drugs and diagnostics) based on a thorough understanding of the gut microbiome, announces that it has entered into a collaborative development agreement with AbbVie.

12 Nov 2014

Qardio receives two CES Innovation Awards for QardioCore wearable ECG monitor

Qardio, Inc., the award-winning maker of smart health solutions for the heart, today announced that it has received two CES Innovation Awards for the upcoming CES 2015 for its QardioCore wearable ECG monitor.

12 Nov 2014

EyeLock named as 2015 CES Innovation Awards Honoree for myris

EyeLock Inc., a market leader of iris-based identity authentication solutions, today announced that it has been named a 2015 CES Innovation Awards Honoree for myris. Products entered in this prestigious program are judged by a preeminent panel of independent industrial designers, independent engineers and members of the trade media to honor outstanding design and engineering in cutting edge consumer electronics products across 28 product categories.

12 Nov 2014

Amedica, Spinal Kinetics sign multi-year OEM agreement for silicon nitride spinal implants

Amedica Corporation, a biomaterial company that has developed silicon nitride ceramics as a material platform to manufacture and commercialize orthopedic implants, is pleased to announce that it has entered into a multi-year original equipment manufacturer (OEM) agreement with Spinal Kinetics, a leading innovator of advanced spinal implant technologies.

12 Nov 2014

MEDICREA receives FDA clearance for world’s first patient-specific spinal osteosynthesis rod

The MEDICREA Group, a company that specializes in the development of personalized implants produced for a patient’s specific need in the treatment of spinal pathologies, today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration for UNiD, the world’s first patient-specific spinal osteosynthesis rod.

12 Nov 2014

Funding makes next-generation scientific equipment available to CBC research community

The Chicago Biomedical Consortium is announcing a $3 million Infrastructure Initiative to promote investment in high-impact, next-generation scientific equipment at its member universities. The Initiative aims to make modern and powerful tools available to the CBC research community at a time when federal grants for scientific infrastructure are scarce.

12 Nov 2014

Crescendo Bioscience to present new data on Vectra DA at ACR Annual Meeting

Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that new data on Vectra DA will be featured at the 2014 American College of Rheumatology Annual Meeting, Nov. 15-19, 2014, in Boston, Massachusetts.

12 Nov 2014

ViewRay's MRIdian system gets CE Mark approval

ViewRay, a privately held medical device company, announced today that its MRIdian (me-rid-i-an) system, the world's first and only MRI-guided radiation therapy system, has received CE Mark (Conformite Europeenne) approval.

11 Nov 2014

Actamax reports positive results from first clinical study of novel sprayable adhesion barrier device

Actamax Surgical Materials LLC, a DSM-DuPont Joint Venture focusing on the development and commercialization of resorbable, biocompatible surgical medical devices, today announced positive safety and efficacy results from the first clinical evaluation of its novel adhesion barrier device.

11 Nov 2014

Device / Technology News

LaVision BioTec introduce new products for their UltraMicroscope and TriM Scope microscopy products at Neuroscience 2014

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

DePuy Synthes releases ViviGen Cellular Bone Matrix for repairing musculoskeletal defects

Scientists use Rapid Heme Panel test to identify right treatment for leukemia, other blood cancers

Researchers develop genetic test to predict prostate cancer recurrence

New DNA-based test could better predict treatment outcomes for prostate cancer patients

K2M receives FDA clearance to market CAPRI Corpectomy Cage System

BioCision announces ThawSTAR™ automated sample thawing system

New multi-specimen perfusion bioreactor for reliable tissue growth introduced by Bose

Encision announces launch of AEM EndoShield Burn Protection System

Antibiograms could improve antibiotic effectiveness, help address problems with antibiotic resistance

Enterome, AbbVie to develop novel diagnostic products, therapies for microbiome-related diseases

Qardio receives two CES Innovation Awards for QardioCore wearable ECG monitor

EyeLock named as 2015 CES Innovation Awards Honoree for myris

Amedica, Spinal Kinetics sign multi-year OEM agreement for silicon nitride spinal implants

MEDICREA receives FDA clearance for world’s first patient-specific spinal osteosynthesis rod

Funding makes next-generation scientific equipment available to CBC research community

Crescendo Bioscience to present new data on Vectra DA at ACR Annual Meeting

ViewRay's MRIdian system gets CE Mark approval

Actamax reports positive results from first clinical study of novel sprayable adhesion barrier device

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News